| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $15.8M | -85.1% |
| Cost of Revenue | $65K | -94.8% |
| R&D Expense | $214.9M | +8.7% |
| SG&A Expense | $74.6M | +35.5% |
| Operating Income | -$282.9M | -97.6% |
| Interest Expense | $41.6M | +255.1% |
| Pre-tax Income | -$306.6M | -139.0% |
| Income Tax | $1.9M | +230.7% |
| Net Income | -$308.5M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $241.4M | +5.9% |
| Inventory | $12.0M | +73.7% |
| Current Assets | $651.9M | +36.7% |
| Total Assets | $831.7M | +18.0% |
| Current Liabilities | $73.7M | -3.0% |
| Long-term Debt | $147.6M | +2.1% |
| Total Liabilities | $624.0M | +172.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$145.9M | -0.6% |
| Capital Expenditures | $7.2M | -59.6% |
| Investing Cash Flow | -$205.7M | -12.6% |
| Financing Cash Flow | $362.7M | — |
| Free Cash Flow | -$153.1M | +5.9% |
| -143.3% |
| EPS (Basic) | -$6.47 | -138.7% |
| EPS (Diluted) | -$6.47 | -138.7% |
| Stockholders' Equity |
| $207.7M |
| -56.4% |